UNSPSC 51281819: Epirubicin hydrochloride

This classification denotes an antineoplastic antibiotic with the molecular formula C27H29NO11.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 22966TX7J5, chemically known as 5,12-naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8s-cis)- but more generally known as epirubicin hydrochloride, which bears US NIH Compound Identifier 32874.

UNSPSC 51281819 Epirubicin hydrochloride, a Commodity code, shows minimal recent state and local procurement activity directly aligned with its nominal scope. The two opportunities posted under this code in the recent record do not substantively reflect purchases of epirubicin hydrochloride or chemotherapy agents; instead, they document awards and solicitations for unrelated pharmaceutical products — doxycycline and ciprofloxacin tablets through a cooperative purchasing vehicle, and naloxone with drug deactivation systems for community health support. The mismatch between the code's name and the actual commodities being procured suggests either miscoding on the posting side or that epirubicin hydrochloride itself does not drive a separate procurement stream under state and local UNSPSC taxonomy at present. Issuing bodies using this code include state health departments (Illinois Department of Public Health) and county-level public health authorities (Seminole County, Florida), typically sourcing through cooperative purchasing consortia or competitive invitation-for-bid processes.

Geographic activity is sparse and limited to Illinois and Florida based on the recent record. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for doxycycline and ciprofloxacin under an IFB process; Seminole County, Florida posted an IFB on June 30, 2026 due July 26, 2026 (note: the due date in the record shows 2023, likely a data error) for naloxone and drug deactivation systems with quarterly deliveries to the county's community health building. Neither opportunity directly reflects chemotherapy-agent procurement. Firms pursuing this code should verify whether their products are correctly mapped to 51281819 or whether alternative UNSPSC classifications better reflect state and local buying patterns for their actual service or product line.